flutamide has been researched along with deoxycytidine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blagden, S; Blesing, C; Corrie, P; D'Ath, S; Mayer, A; Price, P; Shaw, J; Warner, N | 1 |
| Cafasso, D; Konduri, S; Schwarz, MA; Schwarz, RE | 1 |
1 trial(s) available for flutamide and deoxycytidine
| Article | Year |
|---|---|
Phase II study to evaluate combining gemcitabine with flutamide in advanced pancreatic cancer patients.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Female; Flutamide; Gemcitabine; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Pancreatic Neoplasms; Survival Rate; Treatment Outcome | 2002 |
1 other study(ies) available for flutamide and deoxycytidine
| Article | Year |
|---|---|
Androgen receptor blockade in experimental combination therapy of pancreatic cancer.
Topics: Androgen Antagonists; Androgen Receptor Antagonists; Angiogenesis Inhibitors; Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antimetabolites, Antineoplastic; Bevacizumab; Cell Division; Cell Line, Tumor; Deoxycytidine; Dihydrotestosterone; Drug Therapy, Combination; Flutamide; Gemcitabine; Humans; Immunohistochemistry; Mice; Mice, Nude; Pancreatic Neoplasms; Receptors, Androgen; Testosterone; Xenograft Model Antitumor Assays | 2007 |